B+
Bull case
0%
Probability
Target price
$28.00
+20.4% vs current
CC
ChemoursCNYSE / Materials
Last Price
At close
2026-06-02
AI scenario view
RankAlpha Sentiment CodexPost-earnings T+3Most likely
B
Base case
0%
Probability
Target price
$22.00
-5.4% vs current
B-
Bear case
0%
Probability
Target price
$17.00
-26.9% vs current
AI sentiment snapshot
Latest data as of 2026-05-08
Recent news sentiment (30D)
+20.1
Positive
Company
-
Unavailable
Macro
+20.1
Positive
Pulse
+16.6
Positive
Sentiment proxy
+45.7
Score
AI commentary
Post-earnings sentiment is mixed and still fragile. On May 5, 2026, CC closed at $27.94; on May 6 it fell 15.28% to $23.67, and by the May 7 anchor it had fallen to $22.41. That negative reaction came even though MarketBeat showed an EPS beat and even though Mizuho and Truist both raised targets after the print, implying investors are prioritizing the revenue miss and weak TT/APM execution over the guidance reaffirmation. Social coverage was not provided in the packet, so this remains a monitoring-style view rather than a high-conviction turn call.
RankAlpha Sentiment Codex - 2026-05-08
Open post-earnings memoEvidence flagged
No evidence quality warning is currently attached to this memo.
Impact
standard
Confidence
-
AI events
2026-08-06eventQ2 normalization after Washington Works outage and seasonal TSS ramp [#8-K-2026-05-05]High impact
Chemours guided Q2 2026 consolidated adjusted EBITDA to $220 million-$250 million, with APM expected at $12 million-$18 million as Washington Works returns toward normal operations and TSS benefits from seasonal refrigerant demand; a clean delivery would test whether the post-earnings selloff was overdone.
2026-08-06catalystTT and APM weakness can keep the stock in penalty boxHigh impact
Q1 TT adjusted EBITDA fell 64% year over year to $18 million and APM adjusted EBITDA fell 84% to $5 million, with weak cyclical end markets, unfavorable ore mix, mining-footprint changes, and outage-related costs offsetting the stronger TSS result [#8-K-2026-05-05]. If Q2 recovery slips, the market may keep discounting the equity despite higher full-year guidance.
2027-05-08catalystFY2026 deleveraging path depends on TT pricing, TSS demand, and Kuan Yin cash proceeds [#8-K-2026-05-05]High impact
Management reiterated FY2026 net sales growth of 3%-5%, adjusted EBITDA of $800 million-$900 million, free-cash-flow conversion above 20%, and net leverage below 3.8x by year-end; April receipt of about $287 million from the Kuan Yin land sale and partial euro term-loan repayment support the balance-sheet story if operating delivery holds.
Recommendation
N/A
No formal recommendation provided.
As of 2026-05-08 • Updated nightlySource: Internal modelMethodology